PAR •
Healthcare •
Medical Devices •
Quote as of 07/29/2026 09:01
Company Profile
IndustryMedical Devices
SectorHealthcare
ExchangePAR
Market Capitalization29.72 mln
Float169 mln
Earnings Date04/24/2025
EPS
0.10
Marginal
P / E
1.52
Deeply undervalued
Piotroski F-Score
4
/ 9
Borderline
Beneish M-Score
2.96
Highly suspicious
Relative Strength
19
/ 100
Significantly lagging
Debt / Equity
-2.51
Negative equity
Business Description
Founded in Paris in 2000, Mauna Kea Technologies SA develops advanced imaging tools used by physicians across Europe and beyond. The company's flagship product, Cellvizio, gives doctors a live, cellular-level view inside the body during procedures, helping them track disease progression, assess tissue in real time, and make more informed treatment decisions. This technology supports specialists working in digestive, respiratory, and urinary health.
